Enterprise Value

63.81M

Cash

124.3M

Avg Qtr Burn

-34.45M

Short % of Float

3.84%

Insider Ownership

8.38%

Institutional Own.

73.50%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 3

Initiation

PRAX-562 Details
Developmental and Epileptic Encephalopathy

Phase 2

Data readout

Phase 2

Data readout

PRAX-628 Details
Epilepsy, Focal Onset Seizures

Phase 2

Initiation

PRAX-222 Details
Developmental and Epileptic Encephalopathy

Phase 1/2

Data readout

Failed

Discontinued

Failed

Discontinued